Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded …
RF van Vollenhoven, P Geborek, K Forslind… - The Lancet, 2012 - thelancet.com
Summary Background Analysis of the Swedish Farmacotherapy (Swefot) trial at 12 months
showed that the addition of an anti-tumour-necrosis-factor agent gave an improved clinical …
showed that the addition of an anti-tumour-necrosis-factor agent gave an improved clinical …
Incidence of rheumatoid arthritis in Sweden: a nationwide population‐based assessment of incidence, its determinants, and treatment penetration
JK Eriksson, M Neovius, S Ernestam… - Arthritis care & …, 2013 - Wiley Online Library
Objective To estimate the nationwide incidence of rheumatoid arthritis (RA) in Sweden,
including its variation across age, sex, geography, and demography, and to describe the …
including its variation across age, sex, geography, and demography, and to describe the …
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial
S Saevarsdottir, H Wallin, M Seddighzadeh… - Annals of the …, 2011 - ard.bmj.com
Objective To identify predictors of response to methotrexate (MTX) in early rheumatoid
arthritis (RA). Methods In the SWEFOT trial, patients with RA with symptom duration< 1 year …
arthritis (RA). Methods In the SWEFOT trial, patients with RA with symptom duration< 1 year …
Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial
S Saevarsdottir, H Rezaei, P Geborek… - Annals of the …, 2015 - ard.bmj.com
Objectives To study clinical predictors for radiographic progression after 1 year in an early
rheumatoid arthritis (RA) trial. Methods In the SWEFOT trial population, disease modifying …
rheumatoid arthritis (RA) trial. Methods In the SWEFOT trial population, disease modifying …
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully …
H Rezaei, S Saevarsdottir, K Forslind… - Annals of the …, 2012 - ard.bmj.com
Objective To investigate the 2-year clinical and radiological outcomes of patients with early
rheumatoid arthritis (RA; symptom duration< 1 year) who had initially responded well to …
rheumatoid arthritis (RA; symptom duration< 1 year) who had initially responded well to …
Anti–tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis
AI Catrina, E Klint, S Ernestam… - … : Official Journal of …, 2006 - Wiley Online Library
Objective Treatment of rheumatoid arthritis (RA) with tumor necrosis factor (TNF)–blocking
agents, including etanercept and infliximab, has resulted in reductions in the radiographic …
agents, including etanercept and infliximab, has resulted in reductions in the radiographic …
Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden
JT Einarsson, M Willim, S Ernestam, T Saxne… - …, 2019 - academic.oup.com
Objectives The aims of this national study in Sweden of patients with RA were to: examine
the prevalence of sustained remission (SR), that is, remission lasting for at least 6 months; …
the prevalence of sustained remission (SR), that is, remission lasting for at least 6 months; …
International consortium for health outcome measurement set of outcomes that matter to people living with inflammatory arthritis: consensus from an international …
MAH Oude Voshaar, Z Das Gupta… - Arthritis care & …, 2019 - Wiley Online Library
Objective The implementation of value‐based health care in inflammatory arthritis requires a
standardized set of modifiable outcomes and risk‐adjustment variables that is feasible to …
standardized set of modifiable outcomes and risk‐adjustment variables that is feasible to …
[PDF][PDF] Pain over two years after start of biologic versus conventional combination treatment in early rheumatoid arthritis: results from a Swedish randomized controlled …
T Olofsson, JK Wallman, A Jöud… - Arthritis care & …, 2021 - Wiley Online Library
Objective To compare the pain course between methotrexate (MTX)‐refractory early
rheumatoid arthritis (RA) patients randomized to infliximab (IFX) versus sulfasalazine (SSZ) …
rheumatoid arthritis (RA) patients randomized to infliximab (IFX) versus sulfasalazine (SSZ) …
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched …
JK Eriksson, JA Karlsson, J Bratt… - Annals of the …, 2015 - ard.bmj.com
Objective To estimate the incremental cost-effectiveness of infliximab versus conventional
combination treatment over 21 months in patients with methotrexate-refractory early …
combination treatment over 21 months in patients with methotrexate-refractory early …